Skip to main content
Premium Trial:

Request an Annual Quote

New Products: NuGen's Ovation Target Enrichment; HTG Molecular's EdgeSeq Assay

Premium

NuGen has launched its Ovation Target Enrichment System, which uses NuGen's proprietary single primer enrichment technology. The firm has also launched two oncology panels — Ovation Cancer Panel Target Enrichment, which targets over 300 cancer genes, and Ovation Gene Fusion Target Enrichment, which targets over 400 cancer genes that are involved in gene fusions.


HTG Molecular Diagnostics has launched HTG EdgeSeq miRNA Whole Transriptome Assay to analyze the expression of 2,275 microRNAs that are described in the miRBase v20 database. The assay works with formalin-fixed paraffin-embedded tissue samples, is automated on the HTG Edge System and couples HTG Molecular's proprietary nuclease protection chemistry with next-generation sequencing.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.